Blume Capital Management, Inc.
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1587192
BERKELEY, CA
Position in LXRX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$12
New position
Shares Held
5
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#148
of 149 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blume Capital Management, Inc. holds $67,999 across 8 Biotechnology names. LXRX ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
4,484 | $35,199 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
2,300 | $20,136 | |
| 3 | EXEL |
Exelixis, Inc.
|
115 | $6,257 | |
| 4 | MRNA |
Moderna, Inc.
|
45 | $3,151 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
50 | $2,727 | |
| 6 | MNKD |
Mannkind Corp
|
100 | $426 | |
| 7 | INO |
Inovio Pharmaceuticals, Inc.
|
83 | $91 | |
| 8 | LXRX |
Lexicon Pharmaceuticals, Inc.
This page
|
5 | $12 |
All Filings in LXRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12 | 5 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||